Charged Alpha logo
CHARGED ALPHA
Stock Analysis
Stock Library / OSCR
OSCR Healthcare Latest YouTube: Q2 2026 Published 2026-08-09

Oscar Health, Inc.

Live stock metrics, chart context, a quarter-by-quarter episode archive, and a deeper competitor comparison so this page behaves more like an investor workspace than a flat episode link page.

Latest earnings video

Oscar Health Stock (OSCR) Q2 2026 Earnings: The Raised Guide Hides A Second-Half Loss

Published 2026-08-09

Library coverage

Episodes tracked
1
Episodes linked
1
Latest video
Q2 2026
2026-08-09
Podcast available
Yes
Current price
$32.69
+2.04 (+6.66%)
Trailing / Forward P/E
24.22x
Forward: 16.69x
Market cap / Volume
Volume:
Revenue / Earnings Growth
70.4%
Earnings: —
Margins
8.0% op
Gross: 20.2% · Net: 3.6%
Balance sheet
1.08x current
Debt / Equity: 23.5
52-week range / Beta
$10.69 - $33.10
Beta: 2.38
Analyst target
$30.40
Upside: -7.0%
Cash / shareholder return
6.86% FCF yield
Dividend yield: —

Company context

Industry: Healthcare Plans
Country: United States
Employees:
Price to book: 4.91x
Return on equity: 34.3%
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

Price chart

Market context for OSCR

Competitive view

OSCR vs. two close competitors

This section compares the current company against two nearby peers on valuation, growth, margins, balance-sheet strength, and investment setup. Green generally marks the strongest relative figure for that row, while red marks the weakest.

Oscar Health, Inc. latest YouTube video thumbnail YouTube
Oscar Health, Inc.
OSCR
Latest video
Q2 2026
Growth profile looks strong right now, with above-average top-line and/or earnings momentum.
Cash generation stands out versus market value, which helps the stock absorb valuation pressure better than weaker cash converters.
Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.
Expect a more volatile ride than the market average; that can amplify upside, but drawdowns can come fast too.
Intuitive Surgical latest YouTube video thumbnail YouTube
Intuitive Surgical
ISRG
Latest video
Q2 2026
Growth profile looks strong right now, with above-average top-line and/or earnings momentum.
Profitability is a real strength here, with healthy operating margins helping support resilience through weaker cycles.
Valuation already asks investors to pay up, so the upside case depends on continued execution staying strong.
Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.
Johnson & Johnson latest YouTube video thumbnail YouTube
Johnson & Johnson
JNJ
Latest video
Q2 2026
Growth is positive but not explosive, which usually supports a steadier compounding case than a hyper-growth story.
Profitability is serviceable, but it does not obviously dominate peers on margin or cash conversion alone.
Valuation sits in a middle zone where future upside likely depends more on quarterly execution than on multiple re-rating alone.
Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.
Market Cap
More scale can mean deeper resources and resilience, although bigger does not automatically mean better upside.
OSCR
$10.09B
Oscar Health, Inc.
ISRG
$142.77B
Intuitive Surgical
JNJ
$629.14B
Johnson & Johnson
Trailing P/E
Lower trailing P/E can indicate a cheaper valuation relative to trailing earnings, but it may also reflect slower growth or higher perceived risk.
OSCR
24.2x
Oscar Health, Inc.
ISRG
45.8x
Intuitive Surgical
JNJ
30.3x
Johnson & Johnson
Forward P/E
Forward P/E is often a better read on what investors are paying for the next year of earnings power.
OSCR
16.7x
Oscar Health, Inc.
ISRG
33.0x
Intuitive Surgical
JNJ
21.2x
Johnson & Johnson
Revenue Growth
Higher revenue growth usually signals stronger demand, market share gains, or a business still in expansion mode.
OSCR
70.4%
Oscar Health, Inc.
ISRG
18.5%
Intuitive Surgical
JNJ
6.6%
Johnson & Johnson
Earnings Growth
Faster earnings growth matters because it shows management is converting sales momentum into shareholder value.
OSCR
Oscar Health, Inc.
ISRG
26.5%
Intuitive Surgical
JNJ
-0.9%
Johnson & Johnson
Operating Margin
Higher operating margin suggests better operating discipline, pricing power, or a structurally stronger business model.
OSCR
8.0%
Oscar Health, Inc.
ISRG
33.6%
Intuitive Surgical
JNJ
29.2%
Johnson & Johnson
Gross Margin
Gross margin helps show how much product-level pricing power and unit economics a company has before overhead.
OSCR
20.2%
Oscar Health, Inc.
ISRG
66.7%
Intuitive Surgical
JNJ
68.1%
Johnson & Johnson
Net Margin
Higher net margin means more of each dollar of revenue reaches the bottom line after all costs.
OSCR
3.6%
Oscar Health, Inc.
ISRG
28.4%
Intuitive Surgical
JNJ
21.5%
Johnson & Johnson
Return on Equity
ROE shows how efficiently management turns shareholder capital into profits, though leverage can inflate it.
OSCR
34.3%
Oscar Health, Inc.
ISRG
17.4%
Intuitive Surgical
JNJ
25.7%
Johnson & Johnson
Free Cash Flow Yield
Higher free cash flow yield can indicate a stronger cash return relative to the stock's market value.
OSCR
6.9%
Oscar Health, Inc.
ISRG
1.8%
Intuitive Surgical
JNJ
2.7%
Johnson & Johnson
Debt to Equity
Lower leverage usually means less balance-sheet risk, though capital-intensive sectors naturally run higher debt loads.
OSCR
23.46x
Oscar Health, Inc.
ISRG
Intuitive Surgical
JNJ
57.71x
Johnson & Johnson
Current Ratio
A stronger current ratio usually signals better short-term liquidity and more room to absorb shocks.
OSCR
1.08x
Oscar Health, Inc.
ISRG
4.96x
Intuitive Surgical
JNJ
1.09x
Johnson & Johnson
Beta
Lower beta often means lower volatility versus the market, while higher beta usually brings a rougher ride.
OSCR
2.38
Oscar Health, Inc.
ISRG
1.46
Intuitive Surgical
JNJ
0.23
Johnson & Johnson
Dividend Yield
Dividend yield matters for income-focused investors, but a high yield can also reflect a stressed stock price.
OSCR
Oscar Health, Inc.
ISRG
Intuitive Surgical
JNJ
2.0%
Johnson & Johnson
Analyst Upside
Higher analyst upside suggests the Street still sees room between current price and consensus fair value.
OSCR
-7.0%
Oscar Health, Inc.
ISRG
20.0%
Intuitive Surgical
JNJ
4.4%
Johnson & Johnson

Related research

Non-quarter videos featuring OSCR

Special-topic videos, explainers, and shorts connected to this ticker.

All Research Sections
Shorts and Clips 2026-08-09

OSCR Stock: Oscar Health Q2 2026 Earnings - The Raised Guide Hides A Loss #Shorts

A fast Charged Alpha clip pointing viewers into the latest earnings coverage.

Episode timeline

Episode archive for OSCR

Each row is one earnings episode with every verified platform link available.

Q2 2026
Episode live
2026-08-09
Published youtube podcast complete
Oscar Health Stock (OSCR) Q2 2026 Earnings: The Raised Guide Hides A Second-Half Loss
Quarterly earnings-analysis entry for Oscar Health, Inc.. Use the links on the right to open the video or podcast episode.